Sep 4 |
High Growth Tech Stocks To Watch In September 2024
|
Aug 30 |
Travere Therapeutics: Judgement Day Is Nigh For Sparsentan
|
Aug 22 |
Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024
|
Aug 4 |
Travere Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
Aug 3 |
Travere Therapeutics, Inc. (TVTX) Q2 2024 Earnings Call Transcript
|
Aug 1 |
Travere Therapeutics files for mixed shelf offering
|
Aug 1 |
Travere Therapeutics Non-GAAP EPS of -$0.65 beats by $0.07, revenue of $54.12M beats by $1.43M
|
Aug 1 |
Travere Therapeutics Reports Second Quarter 2024 Financial Results
|
Jul 31 |
Travere Therapeutics Q2 2024 Earnings Preview
|
Jul 25 |
Travere Therapeutics to Report Second Quarter 2024 Financial Results
|